Dividends & Buybacks ·
Impact BioMedical completes one-for-12.62 reverse stock split effective September 23
IBOImpact Biomedical Inc.
Impact BioMedical Inc. filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Nevada on September 23, 2026, effecting a one-for-twelve point six two (1-for-12.62) reverse stock split of its common stock. The transaction became effective at 12:01 A.M. EST on that date and began trading on a split-adjusted basis under the existing ticker symbol IBO on the NYSE American with a new CUSIP number. The split reduced the issued and outstanding shares from approximately 107.8 million to 8.6 million, while leaving authorized share count, par value, and voting rights unchanged. Fractional shares were converted to full shares. The filing was delayed due to clerical processing errors by the Nevada Secretary of State, with the company receiving the file-stamped amendment on October 6, 2026. Impact BioMedical Inc. operates in the medical device industry.